Instil Bio
Instil Bio is a clinical-stage cell therapy company that develops tumor infiltrating lymphocytes for the treatment of cancer.
Business Model:
Revenue: $138k
Employees: 201-500
Industries / Tags:
Detailed Instil Bio Information
Geographic Data
Address: 3963 Maple Avenue,
City: Dallas
State: TX
Zip: 75219
Country: US
Financial Info
Stage:
series c
Raised Last:
$0
Raised Total:$200M
Social
Metrics
3,625,311Website Global Rank
3,672Website Monthly Traffic
Twitter Followers
Description
Instil Bio is a clinical-stage cell therapy company that develops tumor infiltrating lymphocytes for the treatment of cancer.
Contact Phone:
+19724993350
Contact Email:
Instil Bio went public on 3/19/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
3/19/2021
IPO Valuation:
$3B
Ticker Symbol:
TIL
IPO Price:
$20/share
Amount Raised:
$320M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2020 | Equity | $170.2M | 4/2019 | Equity | $25M | 9/2019 | Equity | $515.9k | 12/2020 | Equity | $185.4M |
Vivo Capital, LLC Venrock Partners |
3/2021 | IPO | $320M |
|
6/2020 | Series B | $5M | 3/2019 | Series A | $25M | 8/2020 | Series B | $170.2M | 12/2020 | Series C | 1 | - |
HBM Healthcare Investments AG HBM Healthcare Investments AG |
12/2020 | Series C | 1 | - |
HBM Healthcare Investments AG HBM Healthcare Investments AG |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
